title: Chemotherapy versus autologous stem-cell transplantation for the treatment of transformed follicular lymphoma in the rituximab era.
authors.forename: Constantine S
authors.initials: CS
authors.lastname: Tam
authors.forename: Alan
authors.initials: A
authors.lastname: Herschtal
authors.forename: Michael
authors.initials: M
authors.lastname: Dickinson
authors.forename: Anupkumar
authors.initials: A
authors.lastname: George
authors.forename: John F
authors.initials: JF
authors.lastname: Seymour
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008224:Lymphoma, Follicular / Q000401:mortality / Q000628:therapy*; D000069283:Rituximab; D014182:Transplantation, Autologous
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab